|

AZD2265 (FPI-2265) Clinical Trials

1 actively recruiting trial across 1 location

Also known as: 225Ac-PSMA-I&T, FPI-2265

Pipeline

Phase 1/2: 1

Top Sponsors

  • AstraZeneca1

Indications

  • Metastatic Prostate Cancer1
  • Cancer1

Encino, California1 trial

Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer

Research Site

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.